HomeInsights52 Week High Stocks

Genomic Valley Biotech Ltd 52 Week High

Genomic Valley Biotech Ltd 52 Week High

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.5 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

YEARHIGH

₹ 106.85

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Genomic Valley Biotech Ltd is ₹ 106.85 as of 22 Nov 24 .

Company Fundamentals for Genomic Valley Biotech Ltd

No data available

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202498.35
21 Nov 2024100.35
19 Nov 202498.5
18 Nov 202498.5
14 Nov 202498
13 Nov 202497.45
12 Nov 202498.95
11 Nov 2024100.95
08 Nov 2024103
07 Nov 2024105

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Genomic Valley Biotech Ltd News Hub

News

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 O...

Read more

03 Oct 202415:54

News

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 Jul 202410:21

News

Genomic Valley Biotech schedules board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 9 M...

Read more

04 May 202410:44

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

13 Feb 202411:55

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

12 Feb 202411:56

News

Genomic Valley Biotech to conduct board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

05 Feb 202414:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Genomic Valley Biotech Ltd

What is the significance of Genomic Valley Biotech Ltd reaching its 52-week high?

Genomic Valley Biotech Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Genomic Valley Biotech Ltd 52-week high?

Investors monitor Genomic Valley Biotech Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Genomic Valley Biotech Ltd a good buy when it hits its 52-week high?

Whether Genomic Valley Biotech Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Genomic Valley Biotech Ltd fundamentals.

What should I consider before investing in Genomic Valley Biotech Ltd at its 52-week high?

Before investing in Genomic Valley Biotech Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Genomic Valley Biotech Ltd stock price continue to rise after reaching its 52-week high?

Genomic Valley Biotech Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*